Denali Therapeutics Inc.

DNLI - CIK 0001714899

Market cap$3.27 B

Rank#1734

SEC filings763

DNLI balance sheet (annual)

The table below shows Denali Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$205.33M	$174.96M	$127.11M	$218.04M	$293.48M	$507.14M
Short-term investments	$662.55M	$657.37M	$907.40M	$1.12B	$571.93M	$962.55M
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.